Ticker: WINT

Quick take - Windtree Therapeutics, Inc. (NASDAQ: WINT) What's going on inside: management shifted strategy in January 2025 from pure R&D to becoming a parent company that acquires small, revenue-generating businesses and FDA‑approved products. Concurrently the company executed a series of financ...